Cryopyrin-Associated Periodic Syndromes (CAPS) are rare autoinflammatory diseases characterized by dysregulated activation of NLRP3 inflammasome and increased production of interleukin-1 (IL-1) beta, the main mediator of innate inflammation [1, 2]. This evidence concerns the gene IL1B and cryopyrin-associated periodic syndrome.